- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/24 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Patent holdings for IPC class C07D 307/24
Total number of patents in this class: 143
10-year publication summary
|
10
|
11
|
8
|
7
|
9
|
12
|
13
|
9
|
13
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corsair Pharma, Inc. | 38 |
9 |
| Vertex Pharmaceuticals Incorporated | 1588 |
8 |
| BASF SE | 21339 |
7 |
| Bayer AG | 3587 |
5 |
| BioTheryX, Inc. | 98 |
4 |
| Eastman Chemical Company | 2107 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 886 |
4 |
| 3m Innovative Properties Company | 17463 |
3 |
| Genentech, Inc. | 4167 |
3 |
| Boehringer Ingelheim International GmbH | 4490 |
3 |
| Archer Daniels Midland Company | 1074 |
3 |
| Zhejiang Ausun Pharmaceutical Co., Ltd. | 45 |
3 |
| Celloram Inc. | 11 |
3 |
| Novartis AG | 10163 |
2 |
| F. Hoffmann-La Roche AG | 7777 |
2 |
| Hoffmann-La Roche Inc. | 3878 |
2 |
| AstraZeneca AB | 2841 |
2 |
| Syngenta Crop Protection AG | 6825 |
2 |
| Bayer Cropscience AG | 1817 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 387 |
2 |
| Other owners | 70 |